Article Correctness Is Author's Responsibility: Relief for Graft-vs-Host Disease

A drug previously approved for adults with certain types of lymphoma or leukemia has become the first FDA approved medication for chronic graft-vs-host disease (GVHD).
Posted in Uncategorized